Business & Finance
Enzo Biochem incurs higher Q1 GAAP net loss of USD7.6m
11 December 2019 - Life sciences company Enzo Biochem Inc (NYSE:ENZ) disclosed on Tuesday its GAAP net loss of USD7.6m (USD0.16 per share) for the fiscal first quarter ended 31 October 2019.This is a ...
Merrimack Receives USD 5m Milestone Payment from Ipsen
6 December 2019 - - US-based drugmaker Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) has received a USD 5m milestone payment from French drugmaker Ipsen (OTC: IPSEF), triggered by Ipsen's decisi...
KalVista Pharmaceuticals incurs higher net loss of USD5.9m for fiscal second quarter
4 December 2019 - Pharmaceutical company KalVista Pharmaceuticals Inc (NASDAQ:KALV) stated on Tuesday its net loss of USD5.9m (USD0.33) per basic and diluted share for the fiscal second quarter ended ...
Merrimack announces milestone payment from Ipsen and authorises special dividend
4 December 2019 - Biopharmaceutical company Merrimack Pharmaceuticals Inc (Nasdaq:MACK) reported on Tuesday the receipt of USD5m in milestone payment from Ipsen,The milestone payment was triggered by ...
CollPlant announces Q3 2019 financial results
2 December 2019 - CollPlant (NASDAQ: CLGN), a regenerative medicine company, announced on Friday its financial results for the third quarter ended 30 September 2019.The company reported revenues for t...
Can-Fite posts higher net loss of USD7.84m for the nine months ended 30 September 2019
2 December 2019 - Biotechnology company Can-Fite BioPharma Ltd (NYSE American:CANF) (TASE:CFBI) disclosed on Friday that its net loss was USD7.84m for the nine months ended 30 September 2019.This refl...